JPS5811838B2 - Shinko Seibutsutsu BN-165 Shinko Seizouhou - Google Patents

Shinko Seibutsutsu BN-165 Shinko Seizouhou

Info

Publication number
JPS5811838B2
JPS5811838B2 JP50147295A JP14729575A JPS5811838B2 JP S5811838 B2 JPS5811838 B2 JP S5811838B2 JP 50147295 A JP50147295 A JP 50147295A JP 14729575 A JP14729575 A JP 14729575A JP S5811838 B2 JPS5811838 B2 JP S5811838B2
Authority
JP
Japan
Prior art keywords
substance
culture
shinko
methanol
butanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50147295A
Other languages
Japanese (ja)
Other versions
JPS5272892A (en
Inventor
伊藤貢
宮道慎二
江崎紀夫
山田雄次郎
勝俣和子
仁井田太郎
天野昭一
野尻宙平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP50147295A priority Critical patent/JPS5811838B2/en
Publication of JPS5272892A publication Critical patent/JPS5272892A/en
Publication of JPS5811838B2 publication Critical patent/JPS5811838B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Description

【発明の詳細な説明】 本発明はシュードモナス属のバクテリアであるBN−1
65物質生産菌を培養し、培養物から新抗生物質BN−
165物質を分離採取することからなるBN−165物
質の製造法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to BN-1, which is a bacterium of the genus Pseudomonas.
65 substance-producing bacteria were cultured, and the new antibiotic BN-
The present invention relates to a method for producing BN-165 substance, which comprises separating and collecting BN-165 substance.

本発明者らはシュードモナス属に属する特定菌株の培養
物中にダラム陽性の細菌に対し強力な発育阻止作用を示
す物質の存在することを見出し、培養物中から有効成分
を採取して、これをBN−165物質と命名し本発明を
完成した。
The present inventors have discovered that a culture of a specific bacterial strain belonging to the genus Pseudomonas contains a substance that exhibits a strong growth-inhibiting effect on Durum-positive bacteria. The present invention was completed by naming the substance BN-165.

本発明の方法で使用されるシュードモナス属の菌株とし
てはその培養物中に採取するに十分な量のBN−165
物質の生産能を有するものが用いられる。
The Pseudomonas strain used in the method of the present invention contains a sufficient amount of BN-165 to be collected in its culture.
Those that have the ability to produce substances are used.

このような菌株の例としては、本発明者らによって土壌
から新たに分離されたシュードモナスsp、BN−16
5株(菌株番号BN−165株)がある。
Examples of such strains include Pseudomonas sp., BN-16, which was newly isolated from soil by the present inventors.
There are 5 strains (strain number BN-165 strain).

このBN−165株は工業技術院微生物工業技術研究所
に微工研菌寄第3143号(FERM−P No、31
43)として保管されている。
This BN-165 strain was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology, as FERM-P No. 3143 (FERM-P No. 31).
43).

BN−165株の菌学的性状は以下に示すとおりである
The mycological properties of the BN-165 strain are as shown below.

(a)形態的性質 肉汁寒天上で培養した細胞は0.4〜0.6×1.5〜
2.5ミクロンの桿菌であり、極毛性の鞭毛で運動する
(a) Morphological properties Cells cultured on broth agar are 0.4-0.6 x 1.5-
It is a 2.5 micron rod and moves with polar flagella.

胞子は作らず、多形性も示さない。It does not produce spores and shows no pleomorphism.

ダラム染色性は陰性である。(b)培養的性質 ■ 肉汁寒天培養:菌体は淡い茶黄色を呈し、クリーム
様に盛りあがって増殖する。
Durham staining is negative. (b) Culture properties■ Meat juice agar culture: The bacterial cells exhibit a pale brown-yellow color and grow in cream-like mounds.

顕著な粘稠性および遊走性は認められず、 拡散性色素の生成も認められない。No significant viscosity or migration was observed; No formation of diffusible dye was observed.

■ 肉汁液体培養:培地全体が濁り特に液面付近の濁り
が強い。
■ Broth liquid culture: The entire medium becomes cloudy, especially near the liquid surface.

■ 肉汁ゼラチン穿刺培養二袋状に液化される。■ Meat juice gelatin puncture culture is liquefied into two bags.

■ ミルク培養:ゆっくり液化が進行し微酸性を呈す。■ Milk culture: Liquefaction progresses slowly and becomes slightly acidic.

(c)生理的性質 ■ 硝酸塩の還元:陰性 ■ 脱窒反応:陰性 ■ MRテスト:陰性 ■ vpテスト:陰性 ■ インドールの生産:陰性 ■ 硫化水素の生成:鉛糖紙を黒変する ■ デンプンの加水分解:陰性 ■ クエン酸の利用:陽性 ■ 無機窒素源の利用:アンモニウム塩を唯一の窒素源
として利用できる。
(c) Physiological properties ■ Nitrate reduction: negative ■ Denitrification reaction: negative ■ MR test: negative ■ VP test: negative ■ Indole production: negative ■ Hydrogen sulfide generation: turns lead sugar paper black ■ Starch hydration Decomposition: Negative ■ Use of citric acid: Positive ■ Use of inorganic nitrogen source: Ammonium salts can be used as the only nitrogen source.

] 色素の生成:キングAB培地での顕著な合素生成は
認められない。
] Pigment production: No significant pigment production was observed in King AB medium.

■ オキシダーゼ二弱く陽性 ] うさぎ血液寒天二緑変する。■ Oxidase 2 weakly positive ] Rabbit blood agar turns green.

] リジン脱炭酸反応:陽性 0 栄養要求性:ビタミン類、アミノ酸類の栄養要求は
ない。
] Lysine decarboxylation reaction: Positive 0 Auxotrophic requirement: No nutritional requirement for vitamins or amino acids.

] O−Fテスト(ヒユーレイフラン法):パラフィン
シールの有無にかかわらず糖か らガスや酸の生成は認められない。
] O-F test (Hyuleifuran method): No gas or acid generation from sugar is observed with or without a paraffin seal.

] 嫌気的条件下の増殖は認められない。] No growth is observed under anaerobic conditions.

■ 糖の利用性(窒素源としてアンモニウム塩のみを使
用) 1)クルコース、マルトースヲ唯一の炭素源として利用
できる。
■ Utilization of sugar (using only ammonium salt as nitrogen source) 1) Cucrose and maltose can be used as the only carbon source.

11)グリセリン、ガラクトース、シュークロース、マ
ンニットを利用できない。
11) Glycerin, galactose, sucrose, and mannitol cannot be used.

以上の菌学的性質を有するBN−165株をバージニー
ズ・マニュアル・オブ・デターミネイティブ・バクテリ
オロジー第8版(Bergey’s Manual o
f Determinative Bacteriol
−ogy 8th editon)(1974)と比較
し以下の結論を得た。
The BN-165 strain having the above mycological properties was selected from Bergey's Manual of Determinative Bacteriology, 8th edition.
f Determinative Bacteriol
-ogy 8th edition) (1974), and the following conclusions were obtained.

ダラム陰性の桿菌で胞子を作らず、極毛によって運動す
るという形態的性質を有し、絶対好気性であることから
、この菌株はシュードモナス(Pseudomonas
)属に所属すると同定できる。
This strain is a Durham-negative bacillus that does not produce spores, has the morphological characteristics of being motile by polar hairs, and is obligately aerobic, so this strain is Pseudomonas.
) can be identified as belonging to the genus.

BN−165物質生産菌を培養してBN−165物質を
生産蓄積させるには、通常の微生物の発酵に用いられる
各種の培地が用いられる。
In order to culture the BN-165 substance-producing bacteria to produce and accumulate the BN-165 substance, various types of media commonly used for fermentation of microorganisms are used.

すなわち炭素源としてはグルコース、デキストリン、水
あめ等の炭水化物が、才だ窒素源としてはペプトン。
In other words, carbohydrates such as glucose, dextrin, and starch syrup serve as carbon sources, while peptone serves as a nitrogen source.

肉エキス、粉末ブイヨン、コースステイブリカー。Meat extract, powdered bouillon, course stable liquor.

大豆粕、硫酸アンモニウム、塩化アンモニウム等が用い
られる。
Soybean meal, ammonium sulfate, ammonium chloride, etc. are used.

また、食塩や炭酸カルシウム等の無機塩を併用すること
もあり、必要により消泡剤を添加することもある。
Inorganic salts such as common salt and calcium carbonate may also be used together, and an antifoaming agent may be added if necessary.

培養方法としては振盪培養法、深部通気攪拌培養法等の
液体培地を使用する方法が適当である。
Appropriate culture methods include methods using liquid media such as shaking culture and deep aeration agitation culture.

培養温度は20〜35℃の範囲で選択され、培養日数は
1〜3日が適当である。
The culture temperature is selected within the range of 20 to 35°C, and the appropriate number of culture days is 1 to 3 days.

BN−165物質は主として培養液内に蓄積さされる。The BN-165 substance is mainly accumulated in the culture medium.

BN−165物質の検定に当っては、次の方法が用いら
れる。
The following method is used for assaying the BN-165 substance.

検定用培養基としては、ペナツセイアガ−(共栄製薬製
)を用いる。
As the culture medium for assay, Penatuse Agar (manufactured by Kyoei Pharmaceutical Co., Ltd.) is used.

検定菌としてはスタヒロコツカスアウレウス209Pを
用いる。
Staphylococcus aureus 209P is used as the test bacterium.

BN−165物質(純品)はこれを用いた検定において
8mcg/ml〜2000mcg/mlにおいて濃度の
対数と阻止円径との関係は直線関係を示し、それぞれ1
0〜24mm、の阻止円を示す(ペーパーディスク法)
The BN-165 substance (pure product) showed a linear relationship between the logarithm of the concentration and the diameter of the inhibition circle in the range of 8mcg/ml to 2000mcg/ml in an assay using this substance, and each
Indicates an inhibition circle of 0 to 24 mm (paper disk method)
.

BN−165物質は後記する理化学性状を有するので、
その性状に従って抽出、精製することが可能であり、以
下に示す方法が効率的である。
Since the BN-165 substance has the physical and chemical properties described below,
It is possible to extract and purify it according to its properties, and the method shown below is efficient.

即ち有効成分を含む培養液を酸性(pH2〜3)濾過し
固形分を除去後、P液をpH5〜6に調整し、n−ブタ
ノールで有効成分を抽出する。
That is, the culture solution containing the active ingredient is filtered under acidic conditions (pH 2-3) to remove solids, the P solution is adjusted to pH 5-6, and the active ingredient is extracted with n-butanol.

このn−ブタノール層を活性炭で脱色し、n−ブタノー
ル層を濃縮乾固してBN−165物質の粗製品を得る。
This n-butanol layer is decolorized with activated carbon, and the n-butanol layer is concentrated to dryness to obtain a crude product of BN-165 substance.

さらに精製するにはシリカゲル、アルミナ、フロリシー
ル等の吸着剤やゲル濾過剤を使用したクロマトグラフィ
ー向流分配操作あるいは沈澱法等を適宜組みあわせ、精
製し無色粉末を得る。
For further purification, chromatography using an adsorbent such as silica gel, alumina, or Florisil, or a gel filtration agent in combination with an appropriate chromatography countercurrent distribution operation or a precipitation method is used to obtain a colorless powder.

かくして得られたBN−165物質を各種の溶剤での薄
層クロマトグラフィーに付したところ、いずれも単一の
スポットを与え、この粉末がBN−165物質の純品で
あることを示している。
When the BN-165 material thus obtained was subjected to thin layer chromatography in various solvents, each gave a single spot, indicating that this powder was a pure BN-165 material.

BN−165物質の理化学性状は以下に示したとおりで
、塩酸塩として測定したものである。
The physical and chemical properties of the BN-165 substance are as shown below, and were measured as a hydrochloride.

(1)元素分析値:C47,58%、H7,19%、N
13.80%、C17,69%、0 23.74%(差)で、これら以外 の元素は含有していない。
(1) Elemental analysis values: C47.58%, H7.19%, N
13.80%, C17.69%, 0.23.74% (difference), and contains no other elements.

(2)分子量:セファデックスLH−20(ファルマシ
ア社製)によるゲル濾過の結果、 1000〜1200と推定される。
(2) Molecular weight: Estimated to be 1000 to 1200 as a result of gel filtration using Sephadex LH-20 (manufactured by Pharmacia).

後記するアミノ酸分析の結果もほぼ これを支持している。The results of the amino acid analysis described later are also almost the same. I support this.

(3)融点:215℃付近より褐変しはじめ235℃付
近で発泡分解する。
(3) Melting point: It begins to turn brown around 215°C and foams and decomposes around 235°C.

(5)紫外線吸収スペクトル:第1図に示したとおりで
ある。
(5) Ultraviolet absorption spectrum: As shown in FIG.

(6)赤外線吸収スペクトル:第2図に示したとおりで
ある。
(6) Infrared absorption spectrum: As shown in FIG.

(7)溶剤に対する溶解性:メタノール、エタノールに
よく溶け、水にやや溶けるが、 クロロホルム、アセトン、酢酸エチ ル、エチルエーテルにはほとんど溶 けない。
(7) Solubility in solvents: Soluble in methanol and ethanol, slightly soluble in water, but almost insoluble in chloroform, acetone, ethyl acetate, and ethyl ether.

(8)呈色反応:陽性を示すもの、板目、ビウレット、
陰性を示すもの、塩化第2鉄、 フェージング、ニンヒドリン (9)塩基性、酸性、中性の区別二P紙電気泳動の結果
、弱塩基性物質の挙動を示す。
(8) Color reaction: those showing positive, plate grain, biuret,
Those showing negative results: ferric chloride, fading, ninhydrin (9) Distinguishing between basic, acidic, and neutral 2P paper electrophoresis results show the behavior of weakly basic substances.

(10)物質の色:無色粉末 (11)アミノ酸組成:封管中6規定塩酸で110℃2
4時間分解しアミノ酸分析計で分 析した結果、グリシン、ロイシン、 インロイシン、セリン、スレオニン。
(10) Color of substance: colorless powder (11) Amino acid composition: 110℃2 in 6N hydrochloric acid in a sealed tube
The results of 4-hour decomposition and analysis using an amino acid analyzer revealed glycine, leucine, inleucine, serine, and threonine.

アルギニンおよび未知アミノ酸が1 種、合計7種類のアミノ酸が検出さ れ、その含有比はl:3:1:1: 1:1:1である。Arginine and unknown amino acids are 1 A total of 7 types of amino acids were detected. The content ratio is l:3:1:1: The ratio is 1:1:1.

(12)シリカゲル薄層クロマトグラフィーのR4直:
酢酸エチル−酢酸−水(60:17:17) 0.6
3nブタノール−酢酸−水(2:1:1) 0.2
48N−165物質の各種微生物に対する最小発育阻止
濃度は第1表に示したとおりであり、グラム陽性細菌に
強力な阻止作用を示す。
(12) R4 direct of silica gel thin layer chromatography:
Ethyl acetate-acetic acid-water (60:17:17) 0.6
3n Butanol-acetic acid-water (2:1:1) 0.2
The minimum inhibitory concentration of the 48N-165 substance against various microorganisms is as shown in Table 1, and it exhibits a strong inhibitory effect on Gram-positive bacteria.

また本物質の急性毒性はマウスを用いた試験で腹腔内投
与で100mg/kg、経口投与で1000mg/kg
でそれぞれ金側生存した。
In addition, the acute toxicity of this substance was determined to be 100 mg/kg by intraperitoneal administration and 1000 mg/kg by oral administration in tests using mice.
Both sides survived.

BN−165物質は前記した如く、7種類のアミノ酸か
ら成るペグタイド抗生物質である。
As mentioned above, the BN-165 substance is a pegtide antibiotic consisting of seven types of amino acids.

シュードモナス属が生産するペグタイド抗生物質として
は、コミリン(Comirin)ビスコシン(Vi−s
cosin)サイホシンABなどが知られているが、本
物質はこれらとは構成アミノ酸が異る。
Pegtide antibiotics produced by Pseudomonas include Comirin, Viscocin (Vi-s
Cosin) Cyfosin AB is known, but this substance has a different amino acid composition from these.

また、ンユードモナス属以外のバクテリアあるいは放線
菌が生産するペグタイド抗生物質は多数知られているが
、いずれも本物質とは異る。
In addition, many peptide antibiotics produced by bacteria other than the genus Neudomonas or actinobacteria are known, but all of them are different from this substance.

以上の結果からBN−165物質は新抗生物質であると
判定した。
Based on the above results, the BN-165 substance was determined to be a new antibiotic.

以下に本発明の実施例を示すが、本発明においてはここ
に例示しなかった多くの変形あるいは修飾手段を用いう
ろことはもちろんである。
Examples of the present invention are shown below, but it goes without saying that the present invention includes many modifications and modifications not exemplified here.

実施例 1 50〇ml容坂ロフラスコ20本に粉末ブイヨン2%を
含有する液体培地を100−ずつ分注して綿栓を施し、
120℃、10分加圧滅菌しシュードモナスsp、BN
−165株(FERM−No、3143)の斜面培養よ
り一白金耳ずつ植菌した。
Example 1 A liquid medium containing 2% powdered bouillon was dispensed into 20 500ml bouillon flasks in 100ml portions and capped with cotton plugs.
Autoclave sterilized at 120°C for 10 minutes to prepare Pseudomonas sp, BN.
-165 strain (FERM-No. 3143) was inoculated from a slant culture using a platinum loop.

32℃2日間振盪培養してBN−165物質120mc
g/mlを含有する培養液1.81を得た。
120 mc of BN-165 substance was cultured with shaking at 32°C for 2 days.
A culture solution containing 1.81 g/ml was obtained.

この培養液をpH3に調整後濾過し、F液を力性ソーダ
で中和しアンバーライトXAD−2(ロームアンドバー
ス社)200mlの塔を通過させると有効成分は樹脂に
吸着せず通過する。
When this culture solution is adjusted to pH 3 and filtered, and the F solution is neutralized with sodium hydroxide and passed through a 200 ml column of Amberlite XAD-2 (Rohm & Bath Co., Ltd.), the active ingredients pass through without being adsorbed to the resin.

この通過液に1gのnブタノールを加え振盪すると有効
成分はnブタノール層に移行し、このnブタノール層を
減圧濃縮乾固するとBN−165物質の粗粉末180m
9が得られた。
When 1 g of n-butanol is added to this passed liquid and shaken, the active ingredient is transferred to the n-butanol layer. When this n-butanol layer is concentrated to dryness under reduced pressure, 180 m of coarse powder of BN-165 substance is obtained.
9 was obtained.

この粉末をnブタノールに溶解し、予めnブタノールで
充填したシリカゲルの塔にかけnブタノールで展開し活
性区分を減圧濃縮乾固し微黄色の粉末80mgを得た。
This powder was dissolved in n-butanol, poured into a silica gel tower previously filled with n-butanol, developed with n-butanol, and the active fraction was concentrated to dryness under reduced pressure to obtain 80 mg of a slightly yellow powder.

この粉末をさらにメタノールに溶解しセファデックスL
H−20(ファルマシア社)を予めメタノールで膨潤さ
せたカラムにかけメタノールで展開し、活性区分を減圧
濃縮乾固し純度約80%のBN−165物質の粉末28
〜を得た。
This powder was further dissolved in methanol and Sephadex L was added.
H-20 (Pharmacia) was applied to a column previously swollen with methanol, developed with methanol, and the active fraction was concentrated to dryness under reduced pressure to form a powder of BN-165 substance with a purity of about 80%.
I got ~.

実施例 2 ペプトン0.5%、クルコース1%、塩化アンモニウム
0.2%、炭酸カルシウム0.4%、食塩0,3%消消
泡用シリコ抽油0.03を含む培養基151を30/容
培養槽に仕込んで120℃10分殺菌し冷却後あらかじ
め同培地にて2本の坂ロフラスコで1日前培養したシュ
ードモナスsp、BN−165株(FERIVI−P
No、3143)の種を無菌的に培養槽に植菌した。
Example 2 Culture medium 151 containing 0.5% peptone, 1% crucose, 0.2% ammonium chloride, 0.4% calcium carbonate, 0.3% table salt, and 0.03% antifoaming silico extract was prepared at 30/vol. Pseudomonas sp, BN-165 strain (FERIVI-P), which had been cultured in the same culture medium in two Sakalo flasks for 1 day before, was placed in a culture tank, sterilized at 120°C for 10 minutes, and cooled.
No. 3143) was aseptically inoculated into a culture tank.

30℃にて2日間通気攪拌培養(通気量15j/分)、
攪拌数200rp■)し、150mcg/mgの培養液
131を得た。
Aerated agitation culture at 30°C for 2 days (aeration rate 15j/min),
The mixture was stirred at 200 rpm) to obtain a culture solution 131 with a concentration of 150 mcg/mg.

培養液を塩酸でpH2,5に調整後、濾過助剤を用いて
濾過し力性ソーダでF液のpHを5.5にもどし、Sl
ずつのnブタノールでP液から有効成分の抽出を2回行
ない、抽出液を合併し、予めnブタノールで充填したク
ロマト用活性炭素(和光紬薬)の塔を通過させ、さらに
この塔をメタノールで洗い活性区分を減圧濃縮乾固し、
やや油状の粗製品1oyを得た。
After adjusting the culture solution to pH 2.5 with hydrochloric acid, it was filtered using a filter aid, and the pH of solution F was returned to 5.5 with hydrochloric soda.
The active ingredients are extracted from the P solution twice with 100% of n-butanol, the extracts are combined, and passed through a column of activated carbon for chromatography (Wako Tsumugi Pharmaceutical Co., Ltd.) filled with n-butanol in advance, and this column is further extracted with methanol. The washing active fraction was concentrated to dryness under reduced pressure.
1 oy of a slightly oily crude product was obtained.

これを再び200mAのブタノールに溶解し、pH2の
緩衝液200m/ずつで10回抽出し、活性区分の緩衝
液のpHを5に調整し、有効成分をnブタノールで抽出
し、減圧濃縮乾固し黄色粉末2,5Vを得た。
This was dissolved again in 200 mA butanol, extracted 10 times with 200 m/each of pH 2 buffer, adjusted the pH of the buffer in the active section to 5, extracted the active ingredient with n-butanol, and concentrated to dryness under reduced pressure. A yellow powder of 2.5V was obtained.

この粉末をメタノールに溶解し、予めメタノールで充填
したフロリシール(和光紬薬)の塔にかけこの塔をメタ
ノールで洗浄後塩酸でpH2に調整したメタノールで有
効成分を溶出させ活性区分を減圧濃縮乾固しBN−16
5物質の白色粉末400mgを得た。
Dissolve this powder in methanol, apply it to a Florisil (Wako Tsumugi) tower filled with methanol in advance, wash the tower with methanol, elute the active ingredient with methanol adjusted to pH 2 with hydrochloric acid, and concentrate the active fraction to dryness under reduced pressure. ShiBN-16
400 mg of white powder of 5 substances was obtained.

この粉末をメタノールに溶解し、予めメタノールで充填
した酸性アルミナの塔にかけ、メタノール−水−1規定
塩酸(2:1:0.3)で有効成分を溶出させ、活性区
分を減圧濃縮しBN−165物質の純品150/mgを
得た。
This powder was dissolved in methanol, poured into an acidic alumina tower previously filled with methanol, the active ingredient was eluted with methanol-water-1N hydrochloric acid (2:1:0.3), and the active fraction was concentrated under reduced pressure to BN- A pure product of 150/mg of 165 substances was obtained.

実施例 3 ペプトン0.75%、クルコース1.0%、塩化アンモ
ニウム0.3%、炭酸カルシウム0.4%、食塩0.3
%、消泡用シリコン油0.01%を含有する培養基20
01を300g容培養槽に仕込み、120℃、10分殺
菌し冷却後あらかじめ実施例2の培養基にて1日前培養
したシュードモナスsp、BN−165株(FERM−
P扁3143)の種10/を無画部に培養槽に植菌した
Example 3 Peptone 0.75%, crucose 1.0%, ammonium chloride 0.3%, calcium carbonate 0.4%, salt 0.3
%, culture medium containing 0.01% antifoaming silicone oil 20
Pseudomonas sp. BN-165 strain (FERM-01) was placed in a 300 g culture tank, sterilized at 120°C for 10 minutes, and cooled.
Seeds of P. 3143) were inoculated into a culture tank in a non-pictured area.

28℃にて24時間通気攪拌培養(通気量2001/分
攪拌数111105rpし80mcg/mlの培養液1
80jを得た。
24-hour aeration agitation culture at 28°C (aeration rate 2001/min agitation number 111105 rpm, 80 mcg/ml culture solution 1
I got 80j.

培養液をpH2,8に調整し、濾過助剤を用いてフィル
タープレスで沢過後、P液に50kgの硫酸アンモニウ
ムを加え、さらにPH6に調整し、nブタノール100
gずつで2回にわたり有効成分を抽出し、nブタノール
層を合併し減圧下で201に濃縮し生じた不純物の沈澱
を除去した。
The culture solution was adjusted to pH 2.8, filtered with a filter press using a filter aid, 50 kg of ammonium sulfate was added to the P solution, the pH was further adjusted to 6, and n-butanol 100
The active ingredient was extracted twice with 1.5 g each, and the n-butanol layers were combined and concentrated under reduced pressure to a concentration of 2.0 g to remove the resulting impurity precipitate.

このnブタノール層に活性炭300グを投入し、攪拌後
活性炭をF別し、さらに活性炭をメタノールIOJで洗
浄し、前のnブタノール層とこのメタノール層を合併し
減圧濃縮乾固し、褐色の粉末741を得た。
300 g of activated carbon was added to this n-butanol layer, and after stirring, the activated carbon was separated by F, and the activated carbon was further washed with methanol IOJ, and the previous n-butanol layer and this methanol layer were combined and concentrated to dryness under reduced pressure to form a brown powder. I got 741.

この粉末をメタノール500−に溶解し不溶の不純物を
瀘去し予めメタノールで充填したフロリシール800m
1の塔にかけ塩酸酸性メタノール(pH2)で有効成分
を溶出し、活性区分を減圧濃縮し有効成分の白色沈澱を
生ぜしめ、これを涙取してBN−165物質の純品70
0mgを得た。
This powder was dissolved in methanol 500-ml to filter out insoluble impurities, and Floriseal 800ml was filled with methanol in advance.
The active ingredient was eluted with hydrochloric acid and acidic methanol (pH 2), and the active fraction was concentrated under reduced pressure to produce a white precipitate of the active ingredient.
0 mg was obtained.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はBN−165物質の紫外線吸収スペクトルであ
り、BN−165物質をメタノールに1O0100O/
mlの濃度に溶解し測定したものである。 第2図はBN−165物質の赤外線吸収スペクトルであ
り臭化カリウム錠として測定したものである。
Figure 1 shows the ultraviolet absorption spectrum of the BN-165 substance.
It was measured by dissolving the solution in a concentration of 1 ml. FIG. 2 shows an infrared absorption spectrum of the BN-165 substance, measured as a potassium bromide tablet.

Claims (1)

【特許請求の範囲】[Claims] 1 シュードモナス属に属するBN−165物質生産菌
を培養してBN−165物質を蓄積させ、これを採取す
ることを特徴とする新抗生物質BN−165物質の製造
法。
1. A method for producing a new antibiotic BN-165 substance, which comprises culturing a BN-165 substance-producing bacterium belonging to the genus Pseudomonas to accumulate the BN-165 substance, and collecting the BN-165 substance.
JP50147295A 1975-12-12 1975-12-12 Shinko Seibutsutsu BN-165 Shinko Seizouhou Expired JPS5811838B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP50147295A JPS5811838B2 (en) 1975-12-12 1975-12-12 Shinko Seibutsutsu BN-165 Shinko Seizouhou

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50147295A JPS5811838B2 (en) 1975-12-12 1975-12-12 Shinko Seibutsutsu BN-165 Shinko Seizouhou

Publications (2)

Publication Number Publication Date
JPS5272892A JPS5272892A (en) 1977-06-17
JPS5811838B2 true JPS5811838B2 (en) 1983-03-04

Family

ID=15426968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50147295A Expired JPS5811838B2 (en) 1975-12-12 1975-12-12 Shinko Seibutsutsu BN-165 Shinko Seizouhou

Country Status (1)

Country Link
JP (1) JPS5811838B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03101052U (en) * 1990-02-02 1991-10-22
JPH0526657Y2 (en) * 1987-02-06 1993-07-06

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0526657Y2 (en) * 1987-02-06 1993-07-06
JPH03101052U (en) * 1990-02-02 1991-10-22

Also Published As

Publication number Publication date
JPS5272892A (en) 1977-06-17

Similar Documents

Publication Publication Date Title
JPH035398B2 (en)
JP2873340B2 (en) Antibiotic TAN-1057, its production method and use
EP0668358B1 (en) Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
JPS5811838B2 (en) Shinko Seibutsutsu BN-165 Shinko Seizouhou
JPS61247396A (en) Production of genisteine
US4091093A (en) Protease inhibitors
JPH0353891A (en) New antibiotic substance sf2197c and production thereof
CH642397A5 (en) ANTIBIOTIC BN-183B AND PROCESS FOR ITS PREPARATION.
JPS6020000B2 (en) New antibiotic Y-16482 substance and its manufacturing method
US4298599A (en) Novel antibiotic BN-235 substance, and process for the production thereof
JPS5928481A (en) Antibiotic substance y-02039h and preparation thereof
JPS6135832B2 (en)
JPS6029476B2 (en) Cytofuagin and its production method
JPS5813392A (en) Novel antibiotic substance, sf-2107a2, and its preparation
US4235883A (en) Novel antibiotic BN-213 substance and its production
JPH0311096A (en) Novel macrolide antibiotic substance mycinamicins and production thereof
JPS5886087A (en) Novel antibiotic substance sf-2132 and its preparation
JPS62210996A (en) Production of antibiotic substance emimycin
JP3819132B2 (en) Novel bioactive substances NA22598B1 and B2, its production method and its use
JPS6210229B2 (en)
JPS6147491A (en) Antibiotic substance, its preparation, and microorganism
JPH01296992A (en) Substance fr-900493, production thereof and drug composition containing the same substance
JPS5934358B2 (en) Derivative of antibiotic nanaomycin A
JPS5819679B2 (en) New antibiotics and their production methods
JPS6192564A (en) Microorganism producing novel macrolide antibiotic